Stereocomplexes for the delivery of anti-cancer agents
US-2024350644-A1 · Oct 24, 2024 · US
US8946153B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8946153-B2 |
| Application number | US-201113636758-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 28, 2011 |
| Priority date | Mar 29, 2010 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition comprising: (a) at least one matrix-forming agent that is levan to form an open matrix network; and (b) at least one pharmaceutically active ingredient chosen from desmopressin and desmopressin acetate carried by the open matrix network, wherein at least 80% of the composition dissolves within 30 seconds upon contact with an aqueous solution or with saliva, and the composition is an orodispersible pharmaceutical dosage…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.